Metabolic acidosis future or investigational therapies: Difference between revisions
Ochuko Ajari (talk | contribs) No edit summary |
mNo edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
{| class="infobox" style="float:right;" | {| class="infobox" style="float:right;" | ||
|- | |- | ||
| [[File:Siren.gif|30px|link= | |[[File:Siren.gif|30px|link=Metabolic acidosis resident survival guide]]||<br>||<br> | ||
| [[Metabolic acidosis resident survival guide|Resident <br> Survival | |[[Metabolic acidosis resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | ||
|} | |||
{| class="infobox" style="float:right;" | |||
|- | |||
|[[File:Physician_Extender_Algorithms.gif|88px|link=Metabolic acidosis physician extender algorithm]]||<br>||<br> | |||
|} | |} | ||
{{Metabolic acidosis}} | {{Metabolic acidosis}} | ||
{{CMG}} | |||
<br /> | |||
====<u><big>Experimental Treatment:</big></u>==== | |||
Small animal studies of various models of [[shock]] and [[lactic acidosis]] demonstrated improved [[cardiac]] function, reduced [[mortality]], and decreased generation of pro-inflammatory [[cytokines]]; human studies yet to be performed, so options include as follows: | |||
#[[Dichloroacetate]] | |||
#Administration of [[selective inhibitors Na+-H+ Exchanger]] 1 or [[amiloride]] analogues | |||
#Administration of inhibitors of transient receptor potential vanilloid 1 | |||
#Administration of selective inhibitors acid sensing [[Ion channels|Ion channel]] la | |||
#Administration of inhibitors of [[mitogen]] activated protein [[Protein kinase inhibitor|kinase]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 20:09, 19 February 2021
 |
Resident Survival Guide |
| File:Physician Extender Algorithms.gif |
|
Metabolic acidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Metabolic acidosis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Metabolic acidosis future or investigational therapies |
|
FDA on Metabolic acidosis future or investigational therapies |
|
CDC on Metabolic acidosis future or investigational therapies |
|
Metabolic acidosis future or investigational therapies in the news |
|
Blogs on Metabolic acidosis future or investigational therapies |
|
Risk calculators and risk factors for Metabolic acidosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Experimental Treatment:
Small animal studies of various models of shock and lactic acidosis demonstrated improved cardiac function, reduced mortality, and decreased generation of pro-inflammatory cytokines; human studies yet to be performed, so options include as follows:
- Dichloroacetate
- Administration of selective inhibitors Na+-H+ Exchanger 1 or amiloride analogues
- Administration of inhibitors of transient receptor potential vanilloid 1
- Administration of selective inhibitors acid sensing Ion channel la
- Administration of inhibitors of mitogen activated protein kinase